ATAI Life Sciences N.V.
Clinical-stage biopharma creating novel psychedelic drugs for mental health disorders.
ATAI | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- PROF. J.H. BAVINCKLAAN 7, 1183 AMSTELVEEN
- Website:
- https://atai.life/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ATAI Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel treatments for mental health disorders. Founded in 2018, the company's research and development pipeline centers on psychedelics, entactogens, and other innovative drug candidates. ATAI targets conditions with significant unmet patient needs, such as treatment-resistant depression. It operates on a decentralized platform model to accelerate the development of rapid-acting, effective, and durable therapies aimed at transforming patient outcomes in mental health care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ATAI Life Sciences N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ATAI Life Sciences N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ATAI Life Sciences N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
